EMA
approval
· 2025-11-17
EMA Authorised: Corlentor (ivabradine hydrochloride) — Les Laboratoires Servier
Summary
The EMA authorised Corlentor (ivabradine hydrochloride) for use in angina pectoris and heart failure. Les Laboratoires Servier is the marketing authorization ho…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Status: Authorised. Therapeutic area: Angina Pectoris;Heart Failure. MAH: Les Laboratoires Servier. Decision date: 13/11/2025